|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.130 USD | 0.00% |
|
+7.62% | -67.99% |
| 06-30 | ADC Therapeutics SA Completes Enrollment In LOTIS-7 Phase 1b ZYNLONTA Combination Trial | CI |
| 06-30 | ADC Therapeutics Completes Enrollment in LOTIS-7 Lymphoma Study | MT |
| Market Cap | 144M 124M 116M 107M 200M 13.68B 204M 1.36B 535M 6.86B 540M 528M 22.67B | P/E 2026 * |
-1.32x | P/E 2027 * | -1.71x |
|---|---|---|---|---|---|
| Enterprise Value | 144M 124M 116M 107M 200M 13.68B 204M 1.36B 535M 6.86B 540M 528M 22.67B | EV / Sales 2026 * |
1.78x | EV / Sales 2027 * | 1.16x |
| Free-Float |
82.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ADC Therapeutics SA
| 1 week | +7.62% | ||
| Current month | +7.62% | ||
| 1 month | -16.30% | ||
| 3 months | -69.87% | ||
| 6 months | -71.82% | ||
| Current year | -67.99% |
| 1 week | 1.03 |  | 1.17 |
| 1 month | 1.03 | | 1.46 |
| Current year | 0.78 | | 4.98 |
| 1 year | 0.78 | | 4.98 |
| 3 years | 0.36 | | 6.04 |
| 5 years | 0.36 | | 32 |
| 10 years | 0.36 | | 56.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 53 | 08/05/2022 |
Jose Carmona
DFI | Director of Finance/CFO | 54 | 18/12/2022 |
Mohamed Zaki
CTO | Chief Tech/Sci/R&D Officer | 61 | 02/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Hug
BRD | Director/Board Member | 67 | 31/05/2019 |
Tyrell Rivers
BRD | Director/Board Member | 53 | 31/05/2018 |
Ron Squarer
CHM | Chairman | 59 | 29/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/06/26 | Free | Chief Executive Officer | 675,000 | 0.5307% | ||
| 30/06/26 | Free | Chief Financial Officer | 203,700 | 0.1602% | ||
| 30/06/26 | Free | Chief Technology Officer | 213,900 | 0.1682% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +7.62% | -57.20% | -20.98% | 144M | |
| +8.49% | +20.55% | +69.74% | +109.30% | 68.12B | |
| +1.25% | +2.44% | +32.55% | +72.63% | 55.18B | |
| -1.09% | +32.96% | +19.95% | +499.45% | 28.63B | |
| +2.72% | +3.41% | -15.88% | -4.90% | 23.53B | |
| +10.83% | +18.38% | +52.76% | +4.58% | 23.99B | |
| +6.50% | +7.56% | +38.20% | -21.33% | 18.45B | |
| -3.88% | +16.98% | +199.30% | +354.30% | 15.83B | |
| +6.20% | +11.51% | +34.94% | +681.88% | 16.44B | |
| +3.58% | +1.96% | +44.61% | +167.01% | 13.4B | |
| Average | +3.46% | +11.28% | +41.90% | +184.19% | 26.37B | |
| Weighted average by Cap. | +4.35% | +13.09% | +49.42% | +168.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 80.89M 69.97M 65.34M 59.94M 113M 7.7B 115M 767M 301M 3.86B 304M 297M 12.76B | 124M 107M 100M 91.75M 173M 11.78B 175M 1.17B 461M 5.91B 465M 455M 19.53B |
| Net income | -136M -118M -110M -101M -190M -12.96B -193M -1.29B -506M -6.49B -511M -500M -21.47B | -117M -101M -94.77M -86.93M -164M -11.17B -166M -1.11B -436M -5.6B -441M -431M -18.5B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | US$1.130 | 0.00% | 534,554 |
| 06/08/26 | US$1.130 | +5.61% | 722,735 |
| 05/08/26 | US$1.070 | -2.73% | 971,135 |
| 04/08/26 | US$1.100 | +4.76% | 1,368,010 |
| 03/08/26 | US$1.050 | 0.00% | 866,391 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADCT Stock
Select your edition
All financial news and data tailored to specific country editions
